Following the company’s fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technolog...
Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram (Organigram Stock Quote, Chart, News, Analysts, Financials TSX:OGI). On April 1, OGI announced that it would enter ...
Join 8,000+ investors with exclusive access to our email stock alerts. For free.